価格表

在庫・価格 : 2025年04月29日 23時54分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
Anti-Sars Spike Protein, Rabbit-Poly
NB100-56578SS NOVノバス バイオロジカルス
Novus biologicals, LLC
0.025 mg ¥41,000
(未発注)
追加

在庫・価格 : 2025年04月29日 23時54分 現在

Anti-Sars Spike Protein, Rabbit-Poly

  • 商品コード:NB100-56578SS
  • メーカー:NOV
  • 包装:0.025mg
  • 価格: ¥41,000
  • 在庫:無(未発注)
使用文献
No. 文献情報 備考 参照
1 Bertram S et al. Cleavage and activation of the severe acute respiratory syndrome coronavirus spike protein by human airway trypsin-like protease. J. Virol. 2011 Dec;85(24):13363-72
Bertram S et al
2011/01/01
Applications: WB PubMed
2 Watanabe R et al. Entry from the cell surface of severe acute respiratory syndrome coronavirus with cleaved S protein as revealed by pseudotype virus bearing cleaved S protein. J. Virol. 2008 Dec;82(23):11985-91
Watanabe R et al
2008/01/01
Applications: WB PubMed
3 Ujike M et al. Two palmitylated cysteine residues of the severe acute respiratory syndrome coronavirus spike (S) protein are critical for S incorporation into virus-like particles, but not for M-S co-localization. J. Gen. Virol. 2012 Apr;93(Pt 4):823-8
Ujike M et al
2012/01/01
Applications: PubMed
4 Matsuyama S et al. Efficient activation of the severe acute respiratory syndrome coronavirus spike protein by the transmembrane protease TMPRSS2. J. Virol. 2010 Dec;84(24):12658-64
Matsuyama S et al
2010/01/01
Applications: PubMed
5 Simmons G et al. Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry. Proc. Natl. Acad. Sci. U.S.A. 2005 Aug;102(33):11876-81
Simmons G et al
2005/01/01
Applications: ICC/IF PubMed
6 Fukushi S et al. Vesicular stomatitis virus pseudotyped with severe acute respiratory syndrome coronavirus spike protein. J. Gen. Virol. 2005 Aug;86(Pt 8):2269-74
Fukushi S et al
2005/01/01
Applications: PubMed
  • No.: 1
  • 文献情報:
    Bertram S et al. Cleavage and activation of the severe acute respiratory syndrome coronavirus spike protein by human airway trypsin-like protease. J. Virol. 2011 Dec;85(24):13363-72
    Bertram S et al
    2011/01/01
  • 備考:
    Applications: WB
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Watanabe R et al. Entry from the cell surface of severe acute respiratory syndrome coronavirus with cleaved S protein as revealed by pseudotype virus bearing cleaved S protein. J. Virol. 2008 Dec;82(23):11985-91
    Watanabe R et al
    2008/01/01
  • 備考:
    Applications: WB
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Ujike M et al. Two palmitylated cysteine residues of the severe acute respiratory syndrome coronavirus spike (S) protein are critical for S incorporation into virus-like particles, but not for M-S co-localization. J. Gen. Virol. 2012 Apr;93(Pt 4):823-8
    Ujike M et al
    2012/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Matsuyama S et al. Efficient activation of the severe acute respiratory syndrome coronavirus spike protein by the transmembrane protease TMPRSS2. J. Virol. 2010 Dec;84(24):12658-64
    Matsuyama S et al
    2010/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Simmons G et al. Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry. Proc. Natl. Acad. Sci. U.S.A. 2005 Aug;102(33):11876-81
    Simmons G et al
    2005/01/01
  • 備考:
    Applications: ICC/IF
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Fukushi S et al. Vesicular stomatitis virus pseudotyped with severe acute respiratory syndrome coronavirus spike protein. J. Gen. Virol. 2005 Aug;86(Pt 8):2269-74
    Fukushi S et al
    2005/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed